Viking Therapeutics Inc (VKTX)

[Titan V]

If VK5211 data is positive, I think they are highly likely to receive a partnership offer to not just commercialize it (post p3) in hip but also to expand trials in the other indications you mention. This will set a higher share price base before liver data is due in 1H18.

As for me, I'm super excited about the hip data itself, which can come any time this quarter.